Security
DataMeds AI, Inc. Common Stock · MEDS
MEDSNASDAQCommon stockCurrentCIK 2030763Updated Oct 27, 2026
Name history
Wellgistics Health, Inc. · through Jul 21, 2026Danam Health, Inc · through Sep 27, 2024
MEDS price & chart
Loading TradingView…
NASDAQ:MEDS on TradingView ↗About the company
We are currently not authorized to issue any shares of preferred stock. The holders of a majority of the issued and outstanding shares of our common stock approved, by written consent dated August 25, 2026, the Blank Check Amendment. Such stockholder approval will be deemed effective 20 calendar days after the date on which a definitive information statement related thereto is first sent or given to our stockholders. We filed a preliminary information statement with the SEC related thereto on August 31, 2026. As of the date of this prospectus, we have not filed a definitive information statement with the SEC or sent or given a definitive information statement to our stockholders. Promptly after the approval of the Blank Check Amendment by our stockholders is deemed effective, we expect to file the Blank Check Amendment with the Delaware Secretary of State and for it to be effective upon filing, and to promptly thereafter file a certificate of designation that designates 25,000 shares of preferred stock as the Series A Preferred Stock. Certain terms of the Series A Preferred Stock are summarized below:
In the news
4 Explosive Stories Enter the Investor Spotlight ↗
Recent filings
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Entry into a Material Definitive Agreement · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Unregistered Sales of Equity Securities
Items 1.01, 3.01, 3.02
Other Events
Items 8.01
PRE 14C filing
Show 5 more recent filings
S-1/A filing
Other Events
Items 8.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 2.03, 3.02, 7.01, 9.01
PRE 14C filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| AssetsUSD | 52,779,540Source | — | 32,759,432Source | 54,225,015Source | — | 30,127,690Source | 58,063,100Source | — | 30,459,449Source | 57,332,650Source | 338,364Source |
| Property, Plant and Equipment, NetUSD | 268,911Source | — | 173,879Source | 308,642Source | — | 201,514Source | 348,373Source | — | 229,376Source | 388,180Source | — |
| GoodwillUSD | 16,219,929Source | — | 14,193,923Source | 16,219,929Source | — | 14,193,923Source | 16,219,929Source | — | 14,193,923Source | 16,219,929Source | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,244,161Source | — | 2,946,773Source | 2,023,076Source | — | 2,704,641Source | 1,891,150Source | — | 2,499,553Source | 1,618,017Source | — |
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,228,666Source | — | 2,456,373Source | 419,942Source | — | 51,730Source | 2,516,585Source | — | 42,571Source | 1,028,336Source | 1,364Source |
| Accounts ReceivableUSD | 1,099,399Source | — | 1,174,336Source | 2,161,450Source | — | 992,147Source | 2,828,759Source | — | 1,137,219Source | 2,724,814Source | — |
| Inventory, NetUSD | 7,491,900Source | — | 1,510,123Source | 9,031,143Source | — | 1,713,599Source | 9,733,079Source | — | 1,639,426Source | 9,518,608Source | — |
| Assets, CurrentUSD | 12,820,490Source | — | 5,632,638Source | 13,509,643Source | — | 2,761,676Source | 16,551,732Source | — | 2,819,216Source | 15,168,668Source | 338,364Source |
| Operating Lease, Right-of-Use AssetUSD | 1,019,848Source | — | 719,645Source | 1,280,459Source | — | 844,400Source | 1,405,252Source | — | 966,893Source | 1,528,128Source | — |
| Other Assets, NoncurrentUSD | 1,459,607Source | — | — | 1,438,607Source | — | — | 1,421,269Source | — | — | 1,421,269Source | — |
| LIABILITIES AND EQUITY | |||||||||||
| LiabilitiesUSD | 46,001,525Source | — | 52,263,663Source | 53,319,760Source | — | 45,190,139Source | 53,584,332Source | — | 42,907,250Source | 50,598,204Source | 3,238,798Source |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, IssuedUSD | 8,945Source | — | 283Source | 6,315Source | — | 11,940Source | 6,146Source | — | 10,131Source | 5,105Source | 4,472Source |
| Additional Paid in CapitalUSD | 89,947,801Source | — | — | 49,759,467Source | — | 103,699,898Source | 46,660,685Source | — | 98,573,758Source | 16,486,501Source | -3,972Source |
| Retained Earnings (Accumulated Deficit)USD | -83,178,731Source | — | -137,137,512Source | -48,860,527Source | — | -118,774,287Source | -42,188,063Source | — | -111,031,690Source | -9,757,160Source | -2,900,934Source |
| Stockholders' Equity Attributable to ParentUSD | 6,778,015Source | 9,985,092Source | -19,504,231Source | 905,255Source | -3,147,881Source | -15,062,449Source | 4,478,768Source | -2,983,556Source | -12,447,801Source | 6,734,446Source | -2,900,434Source |
| Liabilities and EquityUSD | 52,779,540Source | — | 32,759,432Source | 54,225,015Source | — | 30,127,690Source | 58,063,100Source | — | 30,459,449Source | 57,332,650Source | 338,364Source |
| Current liabilities: | |||||||||||
| Liabilities, CurrentUSD | 32,741,039Source | — | 39,413,823Source | 42,403,542Source | — | 32,198,867Source | 46,225,313Source | — | 29,780,128Source | 38,046,747Source | 2,888,798Source |
| Operating Lease, Liability, CurrentUSD | 503,411Source | — | 566,379Source | 546,255Source | — | 567,748Source | 532,660Source | — | 569,251Source | 519,490Source | — |
| Operating Lease, Liability, NoncurrentUSD | 660,486Source | — | 249,840Source | 816,218Source | — | 391,272Source | 959,019Source | — | 527,122Source | 1,096,372Source | — |
| Additional Financial Items | |||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 27,119,268Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 12,600,000Source | — | 12,600,000Source | 10,100,000Source | — | 12,600,000Source | 24,123,339Source | — | 12,600,000Source | 23,382,901Source | — |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | — | — | 6,400,000Source | — | — | 11,455,085Source | 350,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 12,600,000Source | — | 12,600,000Source | 10,100,000Source | — | 12,600,000Source | — | — | 12,600,000Source | — | — |
| Additional Paid in Capital, Common Stock | — | — | —Source | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 200,000Source | — | — | — | 1,357,764Source | 27,773,421Source | 54,794,525Source | 1,081,106Source | — |
| Changes in operating assets and liabilities: | |||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -51,375Source | 180,098Source | -799,771Source | 40,081Source | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 74,173Source | 214,471Source | -1,890,925Source | 72,356Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,472,242Source | 1,876,683Source | 2,195,822Source | -882,315Source | 1,033,422Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -3,413,129Source | -1,347,449Source | -10,855,029Source | -1,224,993Source | -349,136Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -205,098Source | -273,133Source | -881,526Source | 469,072Source | — |
| Cash flows from financing activities: | |||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,627,386Source | 3,108,831Source | 10,750,790Source | 1,782,893Source | 350,500Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 9,159Source | 1,488,249Source | -985,765Source | 1,026,972Source | 1,364Source |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 132,751Source | 616,072Source | 3,110,776Source | 332,847Source | — |
| Additional Financial Items | |||||||||||
| AmortizationUSD | — | — | — | — | — | — | 328,962Source | 763,064Source | 3,052,260Source | 1,047,048Source | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 25,716,523Source | — | — | 935,222Source | — | — | 54,794,525Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | 12,308Source | — | — | 12,308Source | 12,308Source | 12,308Source | 49,232Source | 26,841Source | — |
| DepreciationUSD | — | — | 39,731Source | 27,174Source | 27,635Source | 39,731Source | 27,862Source | 39,807Source | 158,804Source | 67,616Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -1,353,663Source | — | -8,881,694Source | — | 259,880Source | — | -2,987,922Source | — | — |
| General and Administrative ExpenseUSD | — | — | 30,172,800Source | 1,798,641Source | 7,056,671Source | 4,859,949Source | 4,868,935Source | 31,172,920Source | 70,332,827Source | 6,797,782Source | 2,880,603Source |
| GoodwillUSD | — | — | 16,219,929Source | — | 14,193,923Source | 16,219,929Source | 14,193,923Source | 16,219,929Source | 14,193,923Source | 16,219,929Source | — |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 12,554,266Source | — | — |
| Goodwill, Impairment LossUSD | — | — | 0Source | — | — | — | 0Source | 0Source | 12,571,937Source | 0Source | — |
| InterestExpenseNonoperatingUSD | — | — | 1,425,307Source | 137,614Source | 1,561,240Source | 1,184,040Source | 2,072,679Source | 1,094,490Source | 4,579,556Source | 831,467Source | 15,081Source |
| Inventory Write-downUSD | — | — | — | — | 55,000Source | — | — | — | 5,988,257Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -34,318,204Source | -1,867,027Source | -18,363,225Source | -6,672,464Source | -7,742,597Source | -32,430,903Source | -101,274,530Source | -6,856,226Source | -2,895,684Source |
| Nonoperating Income (Expense)USD | — | — | -2,769,875Source | -122,207Source | -11,018,171Source | -1,172,088Source | -1,727,059Source | -1,082,535Source | -7,525,433Source | -711,094Source | -15,081Source |
| Operating ExpensesUSD | — | — | 31,779,341Source | 2,266,064Source | 7,527,258Source | 6,006,128Source | 6,185,759Source | 32,041,009Source | 87,322,678Source | 7,912,446Source | 2,880,603Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 10,000Source | — |
| Amortization of Deferred Charges | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 3,012,904Source | 5,673,868Source | 1,779,860Source | 7,790,865Source | 1,559,563Source | 10,863,443Source | 23,337,860Source | 18,128,831Source | — |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — |
| Operating Income (Loss)USD | — | — | -31,548,329Source | -1,744,820Source | -7,345,054Source | -5,500,376Source | -6,015,538Source | -31,348,368Source | -93,749,097Source | -6,145,132Source | -2,880,603Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -34,318,204Source | -1,867,027Source | -18,363,225Source | -6,672,464Source | -7,742,597Source | -32,430,903Source | -101,274,530Source | -6,856,226Source | -2,895,684Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -34,318,204Source | -1,867,027Source | -18,363,225Source | -6,672,464Source | -7,742,597Source | -32,430,903Source | -101,274,530Source | -6,856,226Source | -2,895,684Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.46Source | -0.04Source | -7.13Source | -5.4Source | -0.07Source | -0.62Source | -1.43Source | -0.15Source | -0.06Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.46Source | -0.04Source | -7.13Source | -5.4Source | -0.07Source | -0.62Source | -1.43Source | -0.15Source | -0.06Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 74,379,403Source | 48,403,775Source | 2,574,669Source | 1,235,423Source | 104,621,250Source | 51,916,787Source | 70,986,200Source | 47,252,081Source | 44,720,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 74,379,403Source | 48,403,775Source | 2,574,669Source | 1,235,423Source | 104,621,250Source | 51,916,787Source | 70,986,200Source | 47,252,081Source | 44,720,000Source |
| Interest Expense (non-operating)USD | — | — | 1,425,307Source | 137,614Source | 1,561,240Source | 1,184,040Source | 2,072,679Source | 1,094,490Source | 4,579,556Source | 831,467Source | 15,081Source |
| Additional Financial Items | |||||||||||
| Amortization of Intangible AssetsUSD | — | — | 12,308Source | — | — | 12,308Source | 12,308Source | 12,308Source | 49,232Source | 26,841Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 802,794Source | 467,423Source | 356,597Source | 802,796Source | 356,824Source | 802,872Source | 3,211,064Source | 1,114,664Source | — |
| General and Administrative ExpenseUSD | — | — | 30,172,800Source | 1,798,641Source | 7,056,671Source | 4,859,949Source | 4,868,935Source | 31,172,920Source | 70,332,827Source | 6,797,782Source | 2,880,603Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | — | — | — | 0Source | 0Source | 12,571,937Source | 0Source | — |
| Gross ProfitUSD | — | — | 231,012Source | 521,244Source | 182,204Source | 505,752Source | 170,221Source | 692,641Source | -6,426,419Source | 1,767,314Source | — |
| Labor and Related ExpenseUSD | — | — | 75,341Source | — | — | — | — | — | 60,258Source | — | — |
| Nonoperating Income (Expense)USD | — | — | -2,769,875Source | -122,207Source | -11,018,171Source | -1,172,088Source | -1,727,059Source | -1,082,535Source | -7,525,433Source | -711,094Source | -15,081Source |
| Operating ExpensesUSD | — | — | 31,779,341Source | 2,266,064Source | 7,527,258Source | 6,006,128Source | 6,185,759Source | 32,041,009Source | 87,322,678Source | 7,912,446Source | 2,880,603Source |
| Selling and Marketing ExpenseUSD | — | — | 803,747Source | — | 113,990Source | 343,383Source | 960,000Source | 65,217Source | 1,224,521Source | — | — |
Offerings
Registration 333-298154
Registration 333-295078
Registration 333-288932
- Gross proceeds
- 5000003.0
- Net proceeds
- 4650003.0
- Deal price
- 0.7
- Shares
- 7142861
- Offering price
- $0.70
- Ticker
- WGRX
Registration 333-286981
Registration 333-280945
- Gross proceeds
- 4000000.0
- Net proceeds
- 3720000.0
- Deal price
- 4.5
- Shares
- 888889
- Offering price
- $4.50
- Ticker
- WGRX
Filing attachments
ex99-1.htm · 8-K · 2026-10-26
Exhibit 99.1 DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion in 2025 to $93.4 billion in 2035 Customer Acquisition Plan Leverages Existing Relationship with NFL Alumni Health Final Guidance issued by FDA Provid…
Read attachment ↗ex99-1.htm · 8-K · 2026-10-20
Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. (DBA DATAMEDS SI) 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 www.datamedsai.com RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR. COM FOR IMMEDI…
Read attachment ↗ex4-1.htm · 8-K · 2026-09-16
EX-4.1 3 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) …
Read attachment ↗ex99-1.htm · 8-K · 2026-09-16
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 WEBSITE RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR. COM FOR IMMEDIATE RELEASE DATAMEDS, AI. ACQUIRES HELOMICS AI CANCER DIAGNOSTICS LAB AND PRECISION ONCOLOGY CRO BUSINESSES FROM AXE COMPUTE Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services int…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-18
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update Health Lives Here app launch with NFL Alumni Health expected in September 2026 ───────────────────────────────────────────────────────────────────────────────────────────────────── Revenues grew 14% reaching $1.779M in Q2/26, beating management projections Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to …
Read attachment ↗ex99-1.htm · 8-K · 2026-08-14
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Dear Holders of DataMEDS Holding Company Common Stock: This letter is being furnished to you as a stockholder of DataMEDS Holding Company, a Delaware corporation (“ DataMEDS ”). As previously announced by DataMEDS and Datavault AI Inc., a Delaware corporation (“ Datavault ”), Datavault will be making a voluntary one-time distribution (the “ Distribution ”) of Dream Bowl 2026 Meme Coin tokens (such tokens, the “ Meme Coins ”) to the record holders o…
Read attachment ↗